Press Digest: New York Times business news - Nov 1

Crispr Therapeutics AG

01/11/2023 05:37

Nov 1 (Reuters) - The following are the top stories on
the New York Times business pages. Reuters has not verified
these stories and does not vouch for their accuracy.
    
    - A panel of advisers to the U.S. health regulator said on
Tuesday Vertex Pharmaceuticals  VRTX.O  and CRISPR Therapeutics
 CRSP.BN  could assess potential safety risks of their sickle
cell disease gene therapy after approval.
    
    - A California jury ruled on Tuesday that a crash that
killed a Tesla  TSLA.O  owner and seriously injured two
passengers was not the fault of the carmaker's driver-assistance
software.
    
    - Former President Donald J. Trump sued Michigan's top
elections official, seeking to ensure he would be on the ballot
for the 2024 presidential election.
    
    - The U.S. Senate on Tuesday confirmed Jacob J. Lew as the
next U.S. ambassador to Israel.

 (Compiled by Bengaluru newsroom)
 ((globalnewsmonitoring@thomsonreuters.com))